Hla class i a2 tumor associated antigen peptides and vaccine compositions
CA 2393730 A1 · Owner: Epimmune Inc. · Inventors: Celis, Esteban; Fikes, John; Keogh, Elissa
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A composition or vaccine composition comprising at least one peptide that has less than 600 contiguous amino acids having 100 % identity to a native sequence of CEA, HER2/neu, MAGE2, MAGE3 or p53, the peptide further , comprising at least one epitope selected from Table 6.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 13, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 13, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 13, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.